Company news
DX & VX Co., Ltd. news in 2025
DX & VX Co., Ltd.'s news releases, calls and decks from 2025, newest first.
COREE Announces Discovery of Microbiome Biomarkers Specific to Diabetes and Obesity Patients
September 26, 2025
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).
August 18, 2025
Dx&Vx Signs USD 220 Million Co-Development and License Agreement for mRNA Cancer Vaccine with U.S. Biotech Company
July 30, 2025
Dx&Vx Accelerates Development of Universal COVID-19 Vaccine
May 29, 2025